Theia is a technology driven medical company that is revolutionizing the way clinical doctors deal with cardiovascular diseases. Our advanced digital nursing platform, supported by clinically validated artificial intelligence (AI), aims to seamlessly integrate with coronary computed tomography angiography (CCTA) imaging. This innovative system enables clinicians to accurately evaluate various parameters, such as calcium fraction, extracardiac adipose tissue, stenosis severity, plaque phenotype, and CT-FFR, which is helpful for early detection of atherosclerosis. Therefore, personalized and potentially life-saving treatment plans can be developed for patients throughout the entire scope of care. We provide a comprehensive 6-in-1 artificial intelligence toolkit, and our platform can generate professional quality CT reports in less than 10 minutes. By optimizing the process, Theia's solution promises to reduce workload and manpower requirements by 67%, which means each hospital can save approximately $1.3-5 million annually and pharmaceutical trials can save $30 million.